Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Stanton

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Frontiers in Cellular and Infection Microbiology|August 15, 2020
Human Cytomegalovirus Long Non-coding RNA1.2 Suppresses Extracellular Release of the Pro-inflammatory Cytokine IL-6 by Blocking NF-κB ActivationBetty Lau, Karen Kerr, Quan Gu, et al.
Journal of Virology|August 4, 2021
Human Cytomegalovirus RNA2.7 Is Required for Upregulating Multiple Cellular Genes To Promote Cell Motility and Viral Spread Late in Lytic InfectionBetty Lau, Karen Kerr, Salvatore Camiolo, et al.
The Journal of Clinical Investigation|October 11, 2022
Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibodyTanushree Dangi, Sarah Sanchez, Jacob Class, et al.
The Journal of General Virology|December 8, 2023
Inhibition of human cytomegalovirus replication by interferon alpha can involve multiple anti-viral factorsShabab Chowdhury, Katie A Latham, Andy C Tran, et al.
Pathogens (Basel, Switzerland)|July 30, 2025
Human Cytomegalovirus Immune Evasion of Natural Killer Cells: A Virus for All Seasons?Hannah Preston, Rowan Casey, Elizabeth Ferris, et al.
Iscience|February 2, 2024
Multi-targeted loss of the antigen presentation molecule MR1 during HSV-1 and HSV-2 infectionCarolyn Samer, Hamish E G McWilliam, Brian P McSharry, et al.
Nature Communications|September 21, 2022
Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunityMartin J Scurr, George Lippiatt, Lorenzo Capitani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2007
The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cellsVirginie Prod'homme, Cora Griffin, Rebecca J Aicheler, et al.
Frontiers in Cellular and Infection Microbiology|July 10, 2023
Differential cellular and humoral immune responses in immunocompromised individuals following multiple SARS-CoV-2 vaccinationsRhys T Meredith, Max D Bermingham, Kirsten Bentley, et al.
The Journal of Clinical Investigation|August 4, 2010
Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replicationRichard J Stanton, Katarina Baluchova, Derrick J Dargan, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Frontiers in Cellular and Infection Microbiology|August 15, 2020
Human Cytomegalovirus Long Non-coding RNA1.2 Suppresses Extracellular Release of the Pro-inflammatory Cytokine IL-6 by Blocking NF-κB ActivationBetty Lau, Karen Kerr, Quan Gu, et al.
Journal of Virology|August 4, 2021
Human Cytomegalovirus RNA2.7 Is Required for Upregulating Multiple Cellular Genes To Promote Cell Motility and Viral Spread Late in Lytic InfectionBetty Lau, Karen Kerr, Salvatore Camiolo, et al.
The Journal of Clinical Investigation|October 11, 2022
Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibodyTanushree Dangi, Sarah Sanchez, Jacob Class, et al.
The Journal of General Virology|December 8, 2023
Inhibition of human cytomegalovirus replication by interferon alpha can involve multiple anti-viral factorsShabab Chowdhury, Katie A Latham, Andy C Tran, et al.
Pathogens (Basel, Switzerland)|July 30, 2025
Human Cytomegalovirus Immune Evasion of Natural Killer Cells: A Virus for All Seasons?Hannah Preston, Rowan Casey, Elizabeth Ferris, et al.
Iscience|February 2, 2024
Multi-targeted loss of the antigen presentation molecule MR1 during HSV-1 and HSV-2 infectionCarolyn Samer, Hamish E G McWilliam, Brian P McSharry, et al.
Nature Communications|September 21, 2022
Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunityMartin J Scurr, George Lippiatt, Lorenzo Capitani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2007
The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cellsVirginie Prod'homme, Cora Griffin, Rebecca J Aicheler, et al.
Frontiers in Cellular and Infection Microbiology|July 10, 2023
Differential cellular and humoral immune responses in immunocompromised individuals following multiple SARS-CoV-2 vaccinationsRhys T Meredith, Max D Bermingham, Kirsten Bentley, et al.
The Journal of Clinical Investigation|August 4, 2010
Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replicationRichard J Stanton, Katarina Baluchova, Derrick J Dargan, et al.
Pageof 8